Your account is not claimed yet. You can sign up with ORCID to claim your account.

Anders Ekbom

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Topics

Coronavirus Disease

Oral Anticoagulants

Atrial Fibrillation

Top Venues

European journal of epidemiology

Alimentary pharmacology & therapeutics

Pharmacoepidemiology and drug safety

Karolinska Institutet

Uppsala Universitet Medicinska fakulteten (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Karolinska Institutet

Sweden

Department Head :: Department of Medicine Solna, Clinical Epidemiology Unit, Karolinska University Hospital

Education History

Uppsala Universitet Medicinska fakulteten - Sep 18o 1990

Sweden

PHD :: Surgery

Publications

Max Bell, Anders Ekbom, Marie Linder
COVID-19 and comedications in atrial fibrillation-a case-control study in Stockholm. European journal of epidemiology 38 (3) (2023)
Max Bell, Anders Ekbom, Marie Linder
COVID-19 and comedications in atrial fibrillation-a case-control study in Stockholm. European journal of epidemiology (2023)
Max Bell, Anders Ekbom, Marie Linder
COVID-19 and comedications in atrial fibrillation-a case-control study in Stockholm. European journal of epidemiology 38 (3) (2023)
Max Bell, Anders Ekbom, Marie Linder
COVID-19 and comedications in atrial fibrillation-a case-control study in Stockholm. European journal of epidemiology (2023)
Gabriella Bröms, Helle Kieler, Anders Ekbom, Gissler Mika, Karin Hellgren, Maarit K Leinonen, Lars Pedersen, Marcus Schmitt-Egenolf, Henrik Toft Sorensen, Fredrik Granath
Paediatric infections in the first 3 years of life after maternal anti-TNF treatment during pregnancy. Alimentary pharmacology & therapeutics 52 (5) (2020)
Gabriella Bröms, Helle Kieler, Anders Ekbom, Gissler Mika, Karin Hellgren, Anna-Maria Lahesmaa-Korpinen, Lars Pedersen, Marcus Schmitt-Egenolf, Henrik Toft Sorensen, Fredrik Granath
Anti-TNF treatment during pregnancy and birth outcomes: A population-based study from Denmark, Finland, and Sweden. Pharmacoepidemiology and drug safety 29 (3) (2020)